Published in Medical Patent Business Week, December 22nd, 2006
The generic formulation compares to Klaron by Dermik, whose patent has expired. The market for the brand name product was approximately $25 million in 2005.
Sulfacetamide Sodium Topical Suspension USP 10% (Rx) is indicated for the topical treatment of acne. The Fougera product (NDC #0168-0382-04) is available in 118 mL (4 fl oz) bottles and has begun shipping.
David Klaum, senior vice president, commercial business operations,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week